ImmuCell Corporation
Biotechnology
Healthcare
ICCC
9.03 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
6.10
52 week high
7.60
high
6.24
52 week low
0.00
previous Close
6.25
P/E ratio
market cap
55.72 M
div yield
0
net incoming
502 K
-99.97 %
net profit margin
7.79 %
-10.00 %
operating incoming
570 K
-99.95 %
net change in cash
1.40 M
-99.83 %
cash on hand
6.00 M
-99.87 %
cost of revenue
3.63 M
-99.92 %
top